News Column

Patent Issued for Method for the Hypothermic Perfusion of a Cardiac Organ, and Device for the Implementation

August 25, 2014

By a News Reporter-Staff News Editor at Cardiovascular Week -- Universite Claude Bernard Lyon I (Villeurbanne Cedex, FR) has been issued patent number 8802425, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Universite Claude Bernard Lyon I).

The patent's inventor is Ferrera, Rene (Decines, FR).

This patent was filed on December 8, 2010 and was published online on August 12, 2014.

From the background information supplied by the inventors, news correspondents obtained the following quote: "The present invention relates to the field of removal and storage of organs with a view to their transplantation, both in humans and in animals.

"More particularly, the invention relates to a method for hypothermic perfusion of a cardiac organ and to a perfusion device for carrying out the method.

"Organ transplant operations, put simply, involve at least one defective organ in a living patient being replaced by the healthy and functional corresponding organ from a deceased person or, in the case of kidney transplants for example, from a living person who has agreed to donate one of his or her kidneys to a patient who is ill.

"In practice, the organ or organs that are to be transplanted are removed from a donor and then stored immediately in a hypothermic state in appropriate storage devices for transporting them to the hospital establishment where the transplant operation is to be performed on the patient who is ill. This phase of storage of the transplant organs often proves critical.

"One of the main problems encountered in transplantation procedures is the limited period of preservation of the transplants in a hypothermic state. Thus, for a heart transplant for example, the maximum acceptable duration between the removal of the transplant organ from the donor and its implantation in the recipient is considered to be from 4 to 6 hours. This very short time frame requires that all the participants in the transplantation procedure act with great urgency, from the personnel removing the organs to the personnel performing the transplantation itself, and including the personnel charged with transporting the organs. What is worse, this very brief period of viability of the organ between its removal and its transplantation obviously means that many transplantation operations cannot proceed because the distance between donor and recipient is too great.

"Many technical proposals have hitherto been made for storing organs with a view to their transplantation.

"In particular, in the first instance, there is the customary technique of organ preservation involving rapid cooling followed by cold immersion in a liquid. Unfortunately, this technique does not allow the organ to be preserved in good conditions of viability beyond 4 to 6 hours, especially in the case of a heart transplant for example. Beyond this storage period, considerable degradation is observed in the tissues of the organ that is to be transplanted.

"Moreover, the literature available in the field of transplantation, particularly heart transplantation, specifies that perfusion greatly improves the conditions for survival of a heart transplant compared to preservation by immersion. However, the perfusion of heart transplants, permitting the transport of a beating heart, requires suitable apparatuses that take up a lot of space and are complex and that are provided with a system for recirculating the perfusate at body temperature and with an autonomous power source. For this reason, these apparatuses are often considered too expensive and too complex, and they have not hitherto been developed for practice in human medicine.

"Document WO 2009/132018 A1 describes an organ perfusion device which is compact and involves pressurization of a liquid through the organ. However, this device pressurizes the organ itself through the effect of positive liquid pressures in the organ, which is thus 'inflated' with perfusion liquid. This technique is damaging to the organic tissues and adversely affects their storage."

Supplementing the background information on this patent, NewsRx reporters also obtained the inventor's summary information for this patent: "In light of the disadvantages or limitations of the techniques for storing organs with a view to their transplantation, it is an object of the present invention to make available a solution for conserving organs, in particular hearts, by perfusion, which is simple to implement but at the same time permits considerably longer storage time compared to the existing techniques.

"Another object of the invention is to make available a solution for organ storage which is inexpensive and which allows a reduction in the overall costs of transplantation.

"According to the invention, these objects are achieved by virtue of a method for hypothermic perfusion of a cardiac organ, characterized in that: a) the cardiac organ to be perfused is placed in a first tank, which is refrigerated and sealed and which communicates with pressurizing means, said tank containing a physiological liquid for storage, b) the organ to be perfused is attached by an artery to a nozzle communicating with a second tank, which is provided with an overflow outlet to the first tank, which overflow outlet is equipped with a non-return valve, c) the first tank is intermittently pressurized by way of the pressurizing device in order to perform retrograde pulsatile perfusion, comprising successively at least: i. a 'systole' phase of the cardiac organ during the pressurization of the first tank, in the course of which the physiological liquid penetrates the cavities of the cardiac organ, the perfusate being evacuated into the second tank via the artery communicating with the nozzle, and ii. a 'diastole' phase of the cardiac organ when the first tank is not pressurized, in the course of which the perfusate contained in the second tank exerts a hydrostatic pressure in the artery connected to the nozzle and irrigates the organic tissue.

"The hypothermic perfusion method according to the invention provides a novel solution for storing organs that are to be transplanted, particularly heart transplants, and has several advantages over the known techniques. Firstly, the method according to the invention makes it possible to considerably extend the period of storage of the hearts that are to be transplanted. In particular, this makes it possible in practice to at least double the period of storage compared to storage techniques involving hypothermic immersion and, in some cases, to maintain the viability of the organ for up to 24 hours after its removal.

"Secondly, the method according to the invention proves very simple and inexpensive to implement. It also permits a reduction in the overall cost of transplantation because of the extended period of storage that it permits, which somewhat reduces the urgency that characterizes current transplantation procedures.

"Moreover, the perfusion method according to the invention also allows measurements to be carried out directly on the removed cardiac organ in order to assess its viability, especially by examination of the perfusate pressures at the entry and exit points of the organ.

"In the method according to the invention, the pressure for pressurizing the first tank in the 'diastole' phase is advantageously between 5 and 15 cm H.sub.2O.

"Moreover, in the context of the invention, the physiological liquid that is chosen and used can be a non-sanguineous or sanguineous liquid. In practice, a non-sanguineous liquid will be preferred. Moreover, advantageously, this physiological liquid is also ionically osmotic.

"Preferably, in order to ensure that the organ to be transplanted is stored in optimal conditions, the first tank is kept at a temperature of between C. and C. This temperature corresponds to the ideal temperature for storage of the organ.

"In a preferred embodiment of the method according to the invention, the perfused organ is a non-beating heart, connected by the aorta to the nozzle for communicating with the second tank. In fact, the method according to the invention has been specifically developed and refined for the storage and the transplantation of heart transplants, if appropriate from elderly patients, or even from recently deceased patients, something which is never done at present for heart transplants.

"In this particular context of the storage and perfusion of a heart transplant, the physiological liquid is advantageously filtered at the entry of the left atrium during the 'systole' phases.

"According to another advantageous feature of the method according to the invention carried out on a non-beating heart, a hydrostatic pressure is exerted in the aorta during the 'diastole' phases, the pressure causing the closure of the aortic valves and the retrograde perfusion of the myocardium via the coronary vessels, the perfusate that has irrigated the organ being evacuated into the first tank through the coronary sinus via the right atrium.

"Also in the method according to the invention, in a preferred embodiment thereof, the coronary flow rate and the coronary resistance are measured during the 'diastole' phases by way of sensors positioned in the second tank. Such measurements advantageously provide information on the viability of the perfused organ with a view to its transplantation.

"The invention also relates to providing a device for hypothermic perfusion of a cardiac organ, which device is suitable for carrying out the perfusion method set out above. Thus, this particular device has: a. a first sealed tank able to contain a physiological liquid; b. a second sealed tank communicating, in a sealed manner, with the internal volume of the first tank via a nozzle; c. means for refrigerating the first tank and keeping the latter at a substantially constant temperature; d. means for intermittently pressurizing the internal volume of the first tank.

"According to the invention, the second tank has a safety outlet provided with a non-return valve communicating with the first tank.

"Also according to the invention, the second tank has an outlet for an internal overpressure, which outlet is provided with a filter and with a non-return valve.

"Advantageously, the pressurizing means have an air compressor assembly connected in a sealed manner to the internal volume of the first tank by way of a suitable channel.

"Also according to the invention, the air compressor assembly has a compressed-air generator, which delivers a substantially constant air flow and which is connected to a solenoid valve controlled by a pressure regulator in order to feed the first tank discontinuously via said channel and perform intermittent pressurization of said tank.

"Also advantageously, the solenoid valve and the pressure regulator are powered by a battery or from the mains.

"Finally, the second tank can have pressure sensors for measuring the coronary flow rate and the coronary resistance.

"Various other features will become clear from the following description and by reference to the attached drawings which show non-limiting examples of embodiments of the subject matter of the invention."

For the URL and additional information on this patent, see: Ferrera, Rene. Method for the Hypothermic Perfusion of a Cardiac Organ, and Device for the Implementation. U.S. Patent Number 8802425, filed December 8, 2010, and published online on August 12, 2014. Patent URL:

Keywords for this news article include: Surgery, Angiology, Cardiology, Heart Transplant, Organ Transplant, Universite Claude Bernard Lyon I.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Cardiovascular Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters